BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32839832)

  • 1. Intraoperative blood loss as an independent prognostic factor for curative resection after neoadjuvant chemotherapy for gastric cancer: a single-center retrospective cohort study.
    Hayashi M; Yoshikawa T; Yura M; Otsuki S; Yamagata Y; Morita S; Katai H; Nishida T
    Surg Today; 2021 Feb; 51(2):293-302. PubMed ID: 32839832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraoperative Blood Loss is Associated with Shortened Postoperative Survival of Patients with Stage II/III Gastric Cancer: Analysis of a Multi-institutional Dataset.
    Ito Y; Kanda M; Ito S; Mochizuki Y; Teramoto H; Ishigure K; Murai T; Asada T; Ishiyama A; Matsushita H; Tanaka C; Kobayashi D; Fujiwara M; Murotani K; Kodera Y
    World J Surg; 2019 Mar; 43(3):870-877. PubMed ID: 30377722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of intraoperative blood loss on survival after curative resection for gastric cancer.
    Liang YX; Guo HH; Deng JY; Wang BG; Ding XW; Wang XN; Zhang L; Liang H
    World J Gastroenterol; 2013 Sep; 19(33):5542-50. PubMed ID: 24023499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraoperative blood loss does not independently affect the survival outcome of gastric cancer patients who underwent curative resection.
    Zhao B; Huang X; Lu H; Zhang J; Luo R; Xu H; Huang B
    Clin Transl Oncol; 2019 Sep; 21(9):1197-1206. PubMed ID: 30689183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Negative impact of intraoperative blood loss on long-term outcome after curative gastrectomy for advanced gastric cancer: exploratory analysis of the JCOG1001 phase III trial.
    Misawa K; Kurokawa Y; Mizusawa J; Takiguchi S; Doki Y; Makino S; Choda Y; Takeno A; Tokunaga M; Sano T; Sasako M; Yoshikawa T; Terashima M;
    Gastric Cancer; 2022 Mar; 25(2):459-467. PubMed ID: 34797440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic effect of neoadjuvant chemotherapy in gastric cancer patients with postoperative complications.
    Eto K; Hiki N; Kumagai K; Shoji Y; Tsuda Y; Kano Y; Yasufuku I; Okumura Y; Tsujiura M; Ida S; Nunobe S; Ohashi M; Sano T; Yamaguchi T
    Gastric Cancer; 2018 Jul; 21(4):703-709. PubMed ID: 29188456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive value of the surgical Apgar score on postoperative complications in advanced gastric cancer patients treated with neoadjuvant chemotherapy followed by radical gastrectomy: a single-center retrospective study.
    Hayashi M; Yoshikawa T; Yura M; Otsuki S; Yamagata Y; Morita S; Katai H; Nishida T
    BMC Surg; 2020 Jul; 20(1):150. PubMed ID: 32652977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood loss and outcomes after resection of colorectal liver metastases.
    Margonis GA; Kim Y; Samaha M; Buettner S; Sasaki K; Gani F; Amini N; Pawlik TM
    J Surg Res; 2016 May; 202(2):473-80. PubMed ID: 27038662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Neoadjuvant Chemotherapy Toxicity and Postoperative Complications on Short-term and Long-term Outcomes After Curative Resection of Gastric Cancer.
    Wu C; Wang N; Zhou H; Wang T; Mao Q; Zhang X; Zhao D
    J Gastrointest Surg; 2020 Jun; 24(6):1278-1289. PubMed ID: 31140064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Impact of Intraoperative Blood Loss on the Survival of Patients With Stage II/III Pancreatic Cancer.
    Tamagawa H; Aoyama T; Yamamoto N; Kamiya M; Murakawa M; Atsumi Y; Numata M; Kazama K; Hara K; Yukawa N; Rino Y; Masuda M; Morinaga S
    In Vivo; 2020; 34(3):1469-1474. PubMed ID: 32354948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical features and prognosis analysis of 21 gastric cancer patients with pathological complete response after neoadjuvant chemotherapy].
    Peng L; Yang W; Zhang Z; Liu H; Hua Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Oct; 20(10):1168-1173. PubMed ID: 29130233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Postoperative complications and their influence on the prognosis factors in gastric cancer patients receiving neoadjuvant treatment].
    Wang TB; Mao QK; Zhang XJ; Zhou H; Guo CG; Chen YT; Zhao DB
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):160-166. PubMed ID: 33508922
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prognostic analysis of neoadjuvant chemotherapy for locally advanced gastric cancer with propensity score matching method].
    Peng L; Yang W; Zhang Z; Zhi C; Zhou X; Liu H; Hua Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1148-1153. PubMed ID: 30370514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk Factors for and Outcomes of Intraoperative Blood Loss in Liver Resection for Hepatocellular Tumors.
    Imai D; Maeda T; Wang H; Shimagaki T; Sanefuji K; Kayashima H; Tsutsui S; Matsuda H; Yoshizumi T; Mori M
    Am Surg; 2021 Mar; 87(3):376-383. PubMed ID: 32993315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of intra-peritoneal fat distribution on intra-operative bleeding volume with D2 lymphadenectomy in Chinese patients with gastric cancer.
    Lv T; Beeharry MK; Zhu ZL
    Asian J Surg; 2019 Jul; 42(7):768-774. PubMed ID: 30573172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A multi-center retrospective study of perioperative chemotherapy for gastric cancer based on real-world data].
    Ding XW; Zheng ZC; Zhao Q; Zhai G; Liang H; Wu X; Zhu ZG; Wang HJ; He QS; He XL; Du YA; Chen LC; Hua YW; Huang CM; Xue YW; Zhou Y; Zhou YB; Wu D; Fang XD; Dai YG; Zhang HW; Cao JQ; Li LP; Chai J; Tao KX; Li GL; Jie ZG; Ge J; Xu ZF; Zhang WB; Li QY; Zhao P; Ma ZQ; Yan ZL; Zheng GL; Yan Y; Tang XL; Zhou X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 May; 24(5):403-412. PubMed ID: 34000769
    [No Abstract]   [Full Text] [Related]  

  • 17. Study protocol of a multicenter phase III randomized controlled trial investigating the efficiency of the combination of neoadjuvant chemotherapy (NAC) and neoadjuvant laparoscopic intraperitoneal hyperthermic chemotherapy (NLHIPEC) followed by R0 gastrectomy with intraoperative HIPEC for advanced gastric cancer (AGC): dragon II trial.
    Beeharry MK; Ni ZT; Yang ZY; Zheng YN; Feng RH; Liu WT; Yan C; Yao XX; Li C; Yan M; Zhu ZG
    BMC Cancer; 2020 Mar; 20(1):224. PubMed ID: 32183736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Posttherapy nodal status, not graded histologic response, predicts survival after neoadjuvant chemotherapy for advanced gastric cancer.
    Fujitani K; Mano M; Hirao M; Kodama Y; Tsujinaka T
    Ann Surg Oncol; 2012 Jun; 19(6):1936-43. PubMed ID: 22187120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Impact of Intraoperative Blood Loss on the Survival After Laparoscopic Surgery for Colorectal Cancer.
    Shibutani M; Maeda K; Kashiwagi S; Hirakawa K; Ohira M
    Anticancer Res; 2021 Sep; 41(9):4529-4534. PubMed ID: 34475079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of the prognostic nutritional index in advanced gastric cancer treated with preoperative chemotherapy.
    Sun J; Wang D; Mei Y; Jin H; Zhu K; Liu X; Zhang Q; Yu J
    J Surg Res; 2017 Mar; 209():37-44. PubMed ID: 28032569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.